HALO CIK: 1159036

Halozyme Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.93
FY22:
0.74
FY23:
0.75
FY24:
1.09
FY25:
0.83
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.18
FY22:
1.10
FY23:
0.99
FY24:
0.98
FY25:
1.70
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.10
FY22:
1.84
FY23:
1.73
FY24:
2.06
FY25:
2.53

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.13
FY23:
0.11
FY24:
0.14
FY25:
0.18
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.79
FY22:
1.54
FY23:
1.54
FY24:
1.56
FY25:
2.30
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.17
FY23:
0.08
FY24:
0.36
FY25:
0.05
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.10
FY22:
1.84
FY23:
1.73
FY24:
2.06
FY25:
2.53

All amounts in billions USD Data sources:SEC EDGARTwelve Data